Gordon Dunn Quoin Pharmaceuticals, Ltd. (QNRX) insider trading activity

QNRX Quotes by TradingView

Gordon Dunn is Chief Financial Officer of Quoin Pharmaceuticals, Ltd.. Currently has a direct ownership of 151,077 shares of QNRX, which is worth approximately $105,753. The most recent transaction as insider was on Dec 23, 2024, when has been sold 122,221 shares (Ordinary Shares) at a price of $0.45 per share, resulting in proceeds of $54,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 151K
423.55% 3M change
n/a 12M change
Total Value Held $105,753

Gordon Dunn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2024
BUY
Open market or private purchase
$54,999 $0.45 p/Share
122,221 Added 44.72%
151,077 Ordinary Shares
Sep 10 2024
BUY
Open market or private purchase
$16,200 $0.81 p/Share
20,000 Added 40.94%
28,856 Ordinary Shares
Sep 09 2024
BUY
Open market or private purchase
$6,996 $0.79 p/Share
8,856 Added 50.0%
8,856 Ordinary Shares
GD

Gordon Dunn

Chief Financial Officer
Ashburn, VA

Track Institutional and Insider Activities on QNRX

Follow Quoin Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QNRX shares.

Notify only if

Insider Trading

Get notified when an Quoin Pharmaceuticals, Ltd. insider buys or sells QNRX shares.

Notify only if

News

Receive news related to Quoin Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on QNRX